Objects
Diouf, Ibrahima, Malpas, Charles B., Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Sharmin, Sifat, Lechner-Scott, Jeannette, Sola, P, Ferraro, D, Grammond, P, Turkoglu, R, Buzzard, K, Skibina, O, Yamout, B, Altintas, A, Gerlach, O, Roos, Izanne, van Pesch, V, Blanco, Y, Maimone, D, Lechner-Scott, J, Bergamaschi, R, Karabudak, R, Iuliano, G, McGuigan, C, Cartechini, E, Barnett, M, Horakova, Dana, Hughes, S, Sa, MJ, Solaro, C, Kappos, L, Ramo-Tello, C, Cristiano, E, Hodgkinson, S, Spitaleri, D, Soysal, A, Petersen, T, Havrdova, Eva Kubala, Slee, M, Butler, E, Granella, F, de Gans, K, McCombe, P, Ampapa, R, Van Wijmeersch, B, van der Walt, A, Butzkueven, H, Prevost, J, Patti, Francesco, Sinnige, LGF, Sanchez-Menoyo, JL, Vucic, S, Laureys, G, Van Hijfte, L, Khurana, D, Macdonell, R, Gouider, R, Castillo-Trivino, T, Gray, O, Shaygannejad, Vahid, Aguera-Morales, E, Al-Asmi, A, Shaw, C, Deri, N, Al-Harbi, T, Fragoso, Y, Csepany, T, Sempere, AP, Trevino-Frenk, I, Schepel, J, Ozakbas, Serkan, Moore, F, Kalincik, T, Izquierdo, Guillermo. Wiley-Blackwell; 2023. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Signori, Alessio, Izquierdo, Guillermo, Duquette, Pierre, Boz, Cavit, Grammond, Pierre, Terzi, Murat, Singhal, Bhim, Alroughani, Raed, Petersen, Thor, Ramo, Cristina, Oreja-Guevara, Celia, Spitaleri, Daniele, Lugaresi, Alessandra, Lechner-Scott, Jeanette, , , , , , , , , , Hupperts, Raymond, , , , , , , , , , , Grand'Maison, Francois, , , Sola, Patrizia, Horakova, Dana, Havrdova, Eva, Prat, Alexandre, Girard, Marc. Sage; 2018. Long-term disability trajectories in primary progressive MS patients: a latent class growth analysis.
Daruwalla, Cyrus, Shaygannejad, Vahid, Eichau, Sara, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Yamout, Bassem, Khoury, Samia J., Sajedi, Seyed Aidin, Turkoglu, Recai, Altintas, Ayse, Skibina, Olga, Ozakbas, Serkan, Buzzard, Katherine, Grammond, P, Karabudak, R, van der Walt, A, Butzkueven, H, Maimone, D, Lechner-Scott, Jeannette, Soysal, A, John, N, Prevost, J, Havrdova, Eva Kubala, Spitaleri, D, Ramo-Tello, C, Gerlach, O, Iuliano, G, Foschi, M, Ampapa, R, van Pesch, V, Barnett, M, Shalaby, N, D'hooghe, M, Horakova, Dana, Kuhle, J, Sa, MJ, Fabis-Pedrini, M, Kermode, A, Mrabet, S, Gouider, R, Hodgkinson, S, Laureys, G, Van Hijfte, L, Macdonell, R, Alroughani, Raed, Oreja-Guevara, C, Cristiano, E, McCombe, P, Sanchez-Menoyo, JL, Singhal, B, Blanco, Y, Hughes, S, Garber, J, Solaro, C, McGuigan, C, Boz, Cavit, Taylor, B, de Gans, K, Habek, M, Al-Asmi, A, Mihaela, S, Castillo Triviño, T, Al-Harbi, T, Rojas, JI, Gray, O, Khurana, D, Patti, Francesco, Van Wijmeersch, B, Grigoriadis, N, Inshasi, J, Oh, J, Aguera-Morales, E, Fragoso, Y, Moore, F, Shaw, C, Baghbanian, SM, Shuey, N, Onofrj, Marco, Willekens, B, Hardy, TA, Decoo, D, Sempere, AP, Field, D, Wynford-Thomas, R, Cunniffe, NG, Roos, I, Malpas, CB, Coles, AJ, Lugaresi, Alessandra, Kalincik, T, Brown, JWL. Sage; 2023. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Jokubaitis, Vilija G., Spelman, Tim, Grammond, Pierre, Van Pesch, Vincent, Pucci, Eugenio, Grand'Maison, François, Hupperts, Raymond, Granella, Franco, Sola, Patrizia, Bergamaschi, Roberto, Iuliano, Gerardo, Spitaleri, Daniele, Kalincik, Tomas, Lechner-Scott, Jeannette, Lorscheider, Johannes, Havrdova, Eva, Horakova, Dana, Duquette, Pierre, Girard, Marc, Prat, Alexandre, Izquierdo, Guillermo. John Wiley & Sons; 2016. Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
Kalincik, Tomas, Kubala Havrdova, Eva, Ozakbas, Serkan, Kappos, Ludwig, Kuhle, Jens, Terzi, Murat, Lechner-Scott, Jeanette, Boz, Cavit, Grand'maison, Francois, Prevost, Julie, Sola, Patrizia, Ferraro, Diana, Horakova, Dana, Granella, Franco, Trojano, M, Bergamaschi, R, Pucci, E, Turkoglu, R, McCombe, PA, Pesch, VV, Van Wijmeersch, B, Solaro, C, Ramo-Tello, C, Izquierdo, Guillermo, Slee, M, Alroughani, R, Yamout, B, Shaygannejad, V, Spitaleri, D, Sánchez-Menoyo, JL, Ampapa, R, Hodgkinson, S, Karabudak, R, Butler, E, Prat, Alexandre, Vucic, S, Jokubaitis, V, Spelman, T, Butzkueven, H, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Onofrj, Marco, Lugaresi, Alessandra. B M J Group; 2019. Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis.
Kalincik, Tomas, Manouchehrinia, Ali, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Grammond, Pierre, Sola, Patrizia, Hupperts, Raymond, Grand'Maison, Francois, Pucci, Eugenio, Boz, Cavit, Alroughani, Raed, Sobisek, Lukas, Lechner-Scott, Jeannette, , , , , , , , , , Jokubaitis, Vilija, , , , , , , , , , , Spelman, Tim, , , , , , , , Horakova, Dana, Havrdova, Eva, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra. Oxford University Press; 2017. Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
Roos, Izanne, Diouf, Ibrahima, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Sola, Patrizia, Sharmin, Sifat, Ferraro, Diana, Grammond, P, Turkoglu, R, Buzzard, K, Skibina, O, Yamou, B, Altintas, A, Gerlach, O, van Pesch, V, Blanco, Y, Horakova, Dana, Maimone, D, Lechner-Scott, Jeannette, Bergamaschi, R, Karabudak, R, McGuigan, C, Cartechini, E, Barnett, M, Hughes, S, Sa, MJ, Solaro, C, Havrdova, Eva Kubala, Ramo-Tello, C, Hodgkinson, S, Spitaleri, D, Soysal, A, Petersen, T, Granella, F, de Gans, K, McCombe, P, Ampapa, R, Van Wijmeersch, B, Patti, Francesco, van der Walt, A, Butzkueven, H, Prevost, J, Sanchez-Menoyo, JL, Laureys, G, Gouider, R, Castillo-Triviño, T, Gray, O, Aguera-Morales, E, Al-Asmi, A, Shaygannejad, Vahid, Shaw, C, Deri, N, Al-Harbi, T, Fragoso, Y, Csepany, T, Sempere, AP, Trevino-Frenk, I, Schepel, J, Moore, F, Malpas, C, Ozakbas, Serkan, Kalincik, T, Izquierdo, Guillermo, Eichau, Sara. Sage Publications Ltd.; 2023. Comparative effectiveness in multiple sclerosis: A methodological comparison.
Kalincik, Tomas, Kister, Ilya, Ozakbas, Serkan, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Alroughani, Raed, Bacon, Tamar E., Terzi, Murat, Boz, C, Grand'Maison, F, Bergamaschi, R, Gerlach, O, Sa, MJ, Kappos, L, Cartechini, E, Lechner-Scott, Jeannette, van Pesch, V, Malpas, Charles B., Shaygannejad, V, Granella, F, Spitaleri, D, Iuliano, G, Maimone, D, Prevost, J, Soysal, A, Turkoglu, R, Ampapa, R, Butzkueven, H, Sharmin, Sifat, Cutter, G, for MSBase Study Group,, Horakova, Dana, Kubala-Havrdova, Eva, Patti, Francesco, Izquierdo, Guillermo, Eichau, Sara. Sage; 2022. Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
Nguyen, Ai-Lan, Havrdova, Eva Kubala, Horakova, Dana, Izquierdo, Guillermo, Kalincik, Tomas, van der Walt, Anneke, Terzi, Murat, Alroughani, Raed, Duquette, Pierre, Girard, Marc, Prat, Alexandre, Boz, Cavit, Sola, Patrizia, Ferraro, Dianna, Lugaresi, Alessandra, Lechner-Scott, Jeannette, Barnett, Michael, Grand'Maison, Francois, Grammond, Pierre, Ramo-Tello, Cristina, Turkoglu, R, McCombe, P, Pucci, E, Trojano, M, Granella, F, Spitaleri, D, Van Pesch, V, Soysal, A, Oreja-Guevara, C, Verheul, F, Vucic, S, Hodgkinson, S, Slee, M, Ampapa, R, Prevost, J, Menoyo, JLS, Skibina, O, Solaro, C, Olascoaga, J, Shaw, C, Madsen, KG, Naidoo, K, Hyde, R, Butzkueven, H, Jokubaitis, V. Elsevier; 2019. Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: a contemporary cohort study.
Brown, J. William L., Coles, Alasdair, Horakova, Dana, Havrdova, Eva, Izquierdo, Guillermo, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Trojano, Maria, Lugaresi, Alessndra, Bergamaschi, Roberto, Grammond, Pierre, Alroughani, Raed, Hupperts, Raymond, McCombe, Pamela, Van Pesch, Vincent, Sola, Patrizia, Ferraro, Diana, Grand'Maison, Francois, Terzi, Murat, Lechner-Scott, Jeannette. American Medical Association; 2019. Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis.
Le, Minh, Malpas, Charles, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Larochelle, Catherine, Alroughani, Raed, Bergamaschi, Roberto, Sola, Patrizia, Ferraro, Diana, Grammond, Pierre, Grand’ Maison, Francois, Sharmin, Sifat, Lechner-Scott, Jeannette, Boz, C, Hupperts, R, Butzkueven, H, Pucci, E, Granella, F, Van Pesch, V, Soysal, A, Yamout, BI, Lechner-Scott, J, Horáková, Dana, Spitaleri, DLA, Ampapa, R, Turkoglu, R, Iuliano, G, Ramo-Tello, C, Sanchez-Menoyo, JL, Sidhom, Y, Gouider, R, Shaygannejad, V, Prevost, J, Havrdova, Eva, Altintas, A, Fragoso, YD, McCombe, PA, Petersen, T, Slee, M, Barnett, MH, Vucic, S, Van Der Walt, A, Kalincik, T, Trojano, Maria, Izquierdo, Guillermo, Eichau, Sara, Ozakbas, Serkan, Lugaresi, Alessandra. Sage Publications; 2021. Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.
Vitkova, Marianna, Diouf, Ibrahima, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Larochelle, Catherine, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Malpas, Charles, Sola, Patrizia, Ferraro, D, Grammond, P, Butzkueven, H, Buzzard, K, Skibina, O, Yamout, BI, Karabudak, R, Gerlach, O, Lechner-Scott, Jeannette, Horakova, Dana, Maimone, D, Bergamaschi, R, Van Pesch, V, Iuliano, G, Cartechini, E, José Sà, M, Ampapa, R, Barnett, M, Hughes, SE, Ramo-Tello, CM, Kubala Havrdova, Eva, Hodgkinson, S, Spitaleri, DLA, Petersen, T, Butler, EG, Slee, M, McGuigan, C, McCombe, PA, Granella, F, Cristiano, E, Prevost, J, Patti, Francesco, Taylor, BV, Sãnchez-Menoyo, JL, Laureys, G, Van Hijfte, L, Vucic, S, Macdonell, RA, Gray, O, Olascoaga, J, Deri, N, Fragoso, YD, Ozakbas, Serkan, Shaw, C, Kalincik, T, MSBase Study Group,, Izquierdo, Guillermo, Eichau, Sara, Shaygannejad, Vahid. Wolters Kluwer Health; 2022. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study.
Lorscheider, Johannes, Buzzard, Katherine, Jokubaitis, Vilija, Spelman, Tim, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Girard, Marc, Duquette, Pierre, Prat, Alexandre, Lugaresi, Alessandra, Grand'Maison, François, Grammond, Pierre, Hupperts, Raymond, Alroughani, Raed, Sola, Patrizia, Boz, Cavit, Pucci, Eugenio, Lechner-Scott, Jeanette, Bergamaschi, Roberto, Oreja-Guevara, Celia, Iuliano, Gerardo, Van Pesch, Vincent, Granella, Franco, Ramo-Tello, Cristina, Spitaleri, Daniele, Petersen, Thor, Slee, Mark, Verheul, Freek, Ampapa, Radek, Amato, Maria Pia, McCombe, Pamela, Vucic, Steve, Sánchez Menoyo, José Luis, Cristiano, Edgardo, Barnett, Michael H., Hodgkinson, Suzanne, Olascoaga, Javier, Laura Saladino, Maria, Havrdova, Eva, Gray, Orla, Shaw, Cameron, Moore, Fraser, Butzkueven, Helmut, Kalincik, Tomas. Oxford University Press; 2016. Defining secondary progressive multiple sclerosis.
Roos, Izanne, Leray, Emmanuelle, Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Ozakbas, Serkan, Bergamaschi, Roberto, Frascoli, Federico, Sá, Maria José, Cartechini, E, Boz, C, Granella, F, Hupperts, R, Terzi, M, Lechner-Scott, Jeannette, Spitaleri, D, Van Pesch, V, Soysal, A, Casey, Romain, Olascoaga, J, Prevost, J, Aguera-Morales, E, Slee, M, Csepany, T, Turkoglu, R, Sidhom, Y, Gouider, R, Van Wijmeersch, B, McCombe, P, Brown, J. William L., Macdonell, R, Coles, A, Malpas, CB, Butzkueven, H, Vukusic, S, Kalincik, T, , , Horakova, Dana, Havrdova, Eva K., Trojano, Maria, Patti, Francesco, Izquierdo, Guillermo. Oxford University Press; 2020. Delay from treatment start to full effect of immunotherapies for multiple sclerosis.
Roos, Izanne, Leray, Emmanuelle, Izquierdo, Guillermo, Eichau, Sara, Edan, Gilles, Prat, Alexandre, Girard, Marco, Duquette, Pierre, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, Ciron, Jonathon, Frascoli, Federico, Ruet, A, Ozakbas, S, De Seze, J, Louapre, C, Zephir, H, Sá, MJ, Sola, P, Ferraro, D, Labauge, P, Defer, G, Casey, Romain, Bergamaschi, R, Lebrun-Frenay, C, Boz, C, Cartechini, E, Moreau, T, Laplaud, D, Lechner-Scott, Jeanette, Grand’Maison, F, Gerlach, O, Terzi, M, Brown, J. William L., Granella, F, Alroughani, R, Iuliano, G, Van Pesch, V, Van Wijmeersch, B, Spitaleri, DLA, Soysal, A, Berger, E, Prevost, J, Aguera-Morales, E, Horakova, Dana, McCombe, P, Castillo Triviño, T, Clavelou, P, Pelletier, J, Turkoglu, R, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Sidhom, Y, Havrdova, Eva Kubala, Gouider, R, Csepany, T, Bourre, B, Al Khedr, A, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanche, JP, Maurousset, A, Debouverie, Marc, Patry, I, Hankiewicz, K, Pottier, C, Maubeuge, N, Labeyrie, C, Nifle, C, Coles, A, Malpas, CB, Vukusic, S, Butzkueven, H, Trojano, Maria, Kalincik, T, Patti, Francesco. Sage Publications; 2021. Determinants of therapeutic lag in multiple sclerosis.
Fambiatos, Adam, Jokubaitis, Vilija, Grand'Maison, Francois, Grammond, Pierre, Sola, Patricia, Ferraro, Diana, Alroughani, Raed, Terzi, Murat, Hupperts, Raymond, Boz, Cavit, Lechner-Scott, Jeannette, Pucci, Eugenio, Horakova, Dana, Bergamaschi, Roberto, Van Pesch, V, Ozakbas, S, Granella, F, Turkoglu, R, Iuliano, G, Spitaleri, D, McCombe, P, Solaro, C, Slee, M, Kubala Havrdova, Eva Kubala, Ampapa, R, Soysal, A, Petersen, T, Sanchez-Menoyo, JL, Verheul, F, Prevost, J, Sidhom, Y, Van Wijmeersch, B, Vucic, S, Cristiano, E, Trojano, Maria, Saladino, ML, Deri, N, Barnett, M, Olascoaga, J, Moore, F, Skibina, O, Gray, O, Fragoso, Y, Yamout, B, Shaw, C, Prat, Alexandre, Singhal, B, Shuey, N, Hodgkinson, S, Altintas, A, Al-Harbi, T, Csepany, T, Taylor, B, Hughes, J, Jun, J-K, van der Walt, A, Girard, Marc, Spelman, T, Butzkueven, H, Kalincik, T, Duquette, Pierre, Lugaresi, Alessandra, Izquierdo, Guillermo. Sage; 2020. Risk of secondary progressive multiple sclerosis: a longitudinal study.
Lizak, Nathaniel, Lugaresi, Alessandra, Girard, Marc, Prat, Alexandre, Grammond, Pierre, Hupperts, Raymond, Grand'Maison, Francois, Sola, Patrizia, Pucci, Eugenio, Bergamaschi, Roberto, Oreja-Guevara, Celia, Van Pesch, Vincent, Alroughani, Raed, , , , , , , , , , , Lechner-Scott, Jeannette, , , , , , , , Slee, Mark, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Duquette, Pierre. BMJ Group; 2017. Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
Kalincik, Thomas, Cutter, Gary, Prat, Alexandre, Lugaresi, Alessandra, Grand'Maison, Francois, Grammond, Pierre, Hupperts, Raymond, Oreja-Guevara, Celia, Boz, Cavit, Pucci, Eugenio, Bergamaschi, Roberto, Lechner-Scott, Jeannette, Spelman, Tim, Alroughani, Raed, Van Pesch, Vincent, Iuliano, Gerardo, Fernandez-Bolaños, Ricardo, Ramo, Cristina, Terzi, Murat, Slee, Mark, Spitaleri, Daniele, Verheul, Freek, Cristiano, Edgardo, Jokubaitis, Vilija, Sánchez-Menoyo, José Luis, Fiol, Marcela, Gray, Orla, Cabrera-Gomez, Jose Antonio, Barnett, Michael, Butzkueven, Helmut, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Girard, Marc, Duquette, Pierre. Oxford University Press; 2015. Defining reliable disability outcomes in multiple sclerosis.
Harding-Forrester, Sam, Roos, Izanne, Horakova, Dana, Kubala Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand'Maison, Francois, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, Ozakbas, Serkan, Nguyen, Ai-Lan, Amato, Maria Pia, Gerlach, O, Sola, P, Ferraro, D, Buzzard, K, Skibina, O, Lechner-Scott, Jeannette, Alroughani, R, Boz, C, Van Pesch, V, Malpas, Charles B., Cartechini, E, Terzi, M, Maimone, D, Ramo-Tello, C, Yamout, B, Khoury, SJ, La Spitaleri, D, Sa, MJ, Blanco, Y, Granella, F, Diouf, Ibrahima, Slee, M, Butler, E, Sidhom, Y, Gouider, R, Bergamaschi, R, Karabudak, R, Ampapa, R, Sanchez-Menoyo, JL, Prevost, J, Castillo-Trivino, T, Moradi, Nahid, McCombe, PA, Macdonell, R, Laureys, G, Van Hijfte, L, Oh, J, Altintas, A, de Gans, K, Turkoglu, R, van der Walt, A, Butzkueven, H, Sharmin, Sifat, Vucic, S, Barnett, M, Cristiano, E, Hodgkinson, S, Iuliano, G, Kappos, L, Kuhle, J, Shaygannejad, V, Soysal, A, Weinstock-Guttman, B, Izquierdo, Guillermo, Van Wijmeersch, B, Kalincik, T, Eichau, Sara, Patti, Francesco. BMJ Group; 2023. Disability accrual in primary and secondary progressive multiple sclerosis.
Sharmin, Sifat, Lefort, Mathilde, Onofrj, Marco, Lugaresi, Alessandra, Terzi, Murat, Grammond, Pierre, Grand'Maison, Francois, Yamout, Bassem, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Boz, Cavit, Andersen, Johanna Balslev, Trojano, Maria, McCombe, P, Slee, M, Lechner-Scott, Jeannette, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Prevost, J, Maimone, D, Leray, Emmanuelle, Skibina, O, Buzzard, K, Van der Walt, A, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Casey, R, Debouverie, M, Edan, G, Horakova, Dana, Ciron, J, Ruet, A, De Seze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Havrdova, Eva Kubala, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Alroughani, Raed, Montcuquet, A, Wahab, A, Camdessanche, J-P, Maurousset, A, Patry, I, Hankiewicz, K, Pottier, C, Maubeuge, N, Labeyrie, C, Nifle, C, Izquierdo, Guillermo, Laplaud, D, Koch-Henriksen, N, Sellebjerg, FT, Soerensen, PS, Pfleger, CC, Rasmussen, PV, Jensen, MB, Frederiksen, JL, Bramow, S, Mathiesen, HK, Ozakbas, Serkan, Schreiber, KI, Magyari, M, Vukusic, S, Butzkueven, H, Kalincik, T, Patti, Francesco. Adis International; 2021. Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.
Kalincik, Tomas, Jokubaitis, Vilja, Duquette, Pierre, Grammond, Pierre, Solaro, Claudio, Grand'Maison, Francois, Hupperts, Raymond, Prevost, Julie, Sola, Patrizia, Ferraro, Diana, Terzi, Murat, Butler, Ernest, Spelman, Tim, Slee, Mark, Kermode, Allan, Fabis-Pedrini, Marzena, McCombe, Pamela, Barnett, Michael, Shaw, Cameron, Hodgkinson, Suzanne, Butzkueven, Helmut, MSBase Study Group,, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc. Sage; 2018. Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.
Hughes, Jordana, Jokubaitis, Vilija, Lugaresi, Alessandra, Hupperts, Raymond, Izquierdo, Guillermo, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand'Maison, Francois, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Ramo-Tello, Cristina, Trojano, Maria, Slee, Mark, Shaygannejad, Vahid, Boz, Cavit, Lechner-Scott, Jeanette, Van Pesch, Vincent, Pucci, Eugenio, Solaro, Claudio, Verheul, Freek, Terzi, Murat, Granella, Franco, Spitaleri, Daniele, Alroughani, Raed, Jun, Jae-Kwan, Fambiatos, Adam, Van der Walt, Anneke, Butzkueven, Helmut, Kalincik, Tomas. American Medical Association (AMA); 2018. Association of inflammation and disability accrual in patients with progressive-onset multiple sclerosis.
Spelman, Tim, Horakova, Dana, Csepany, Tunde, Boz, Cavit, Lechner-Scott, Jeannette, Granella, Franco, Grand'Maison, Francois, van der Walt, Anneke, Zhu, Chao, Butzkueven, Helmut, Ozakbas, Serkan, Alroughani, Raed, Onofrj, Marco, Kalincik, Tomas, Prat, Alexandre, Terzi, Murat, Grammond, Pierre, Patti, Francesco. Elsevier; 2023. Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity.
Stewart, Tamasine, Spelman, Tim, Grand'Maison, Francois, Grammond, Pierre, Sola, Patrizia, Shaygannejad, Vahid, Hupperts, Raymond, Alroughani, Raed, Oreja-Guevara, Celia, Pucci, Eugenio, Boz, Cavit, Lechner-Scott, Jeannette, Havrdova, Eva, , , , , , , , , , , Horakova, Dana, , , , , , , , , , , Trojano, Maria, , , , , , , , , , , Izquierdo, Guillermo, , , , , , Duquette, Pierre, Girard, Marc, Prat, Alexandre, Lugaresi, Alessandra. Sage; 2017. Contribution of different relapse phenotypes to disability in multiple sclerosis.
Kalincik, Tomas, Brown, J. William L., McGuigan, Christopher, Jokubaitis, Vilija, Spelman, Tim, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Robertson, Neil, Lechner-Scott, Jeannette, , , , , , , , , , Willis, Mark, , , , , , , , , , , Scolding, Neil, , , , , , , , , , , Rice, Claire M., Wilkins, Alastair, Pearson, Owen, Ziemssen, Tjalf, Hutchinson, Michael. Lancet Publishing; 2017. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.
Lorscheider, Johannes, Jokubaitis, Vilija G., Prat, Alexandre, Grand'Maison, François, Grammond, Pierre, Pucci, Eugenio, Boz, Cavit, Sola, Patrizia, Ferraro, Diana, Spitaleri, Daniele, Lechner-Scott, Jeanette, Terzi, Murat, Spelman, Tim, , , , , , , , , Izquierdo, Guillermo, Lugaresi, Alessandra, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Duquette, Pierre, Girard, Marc. Lippincott Williams & Wilkins; 2017. Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.
Spelman, Tim, Kalincik, Tomas, Havrdová, Eva, Horáková, Dana, Grammond, Pierre, Duquette, Pierre, Prat, Alexandre, Iuliano, Gerardo, Terzi, Murat, Izquierdo, Guillermo, Hupperts, Raymond M.M., , Jokubaitis, Vilija, , , , , Lechner-Scott, Jeannette, , , , , , Zhang, Annie, , Pellegrini, Fabio, Wiendl, Heinz, Belachew, Shibeshih, Hyde, Robert, Verheul, Freek, Lugaresi, Alessandra. Lippincott Williams & Wilkins; 2016. Comparative efficacy of first-line natalizumab vs IFN-ß or glatiramer acetate in relapsing MS.
Sharmin, Sifat, Bovis, Francesca, Duquette, Pierre, Onofrj, Marco, Lugaresi, Alessandra, Grand'Maison, Francois, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Terzi, Murat, Gerlach, Oliver, Alroughani, Raed, Malpas, Charles, Boz, C, Shaygannejad, V, van Pesch, V, Cartechini, E, Kappos, L, Lechner-Scott, Jeanette, Bergamaschi, R, Turkoglu, R, Solaro, C, Iuliano, G, Horakova, Dana, Granella, F, Van Wijmeersch, B, Spitaleri, D, Slee, M, McCombe, P, Prevost, J, Ampapa, R, Ozakbas, S, Sanchez-Menoyo, JL, Soysal, A, Havrdova, Eva Kubala, Vucic, S, Petersen, T, de Gans, K, Butler, E, Hodgkinson, S, Sidhom, Y, Gouider, R, Cristiano, E, Castillo-Trivino, T, Saladino, ML, Izquierdo, Guillermo, Barnett, M, Moore, F, Rozsa, C, Yamout, B, Skibina, O, van der Walt, A, Buzzard, K, Gray, O, Hughes, S, Sempere, AP, Eichau, Sara, Singhal, B, Fragoso, Y, Shaw, C, Kermode, A, Taylor, B, Simo, M, Shuey, N, Al-Harbi, T, Macdonell, R, Dominguez, JA, Trojano, Maria, Csepany, T, Sirbu, CA, Sormani, MP, Butzkueven, H, Kalincik, T, Prat, Alexandre, Girard, Marc. Wiley-Blackwell; 2022. Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Roos, Izanne, Malpas, Charles, Eichau, Sara, Edan, Gilles, Prat, Alexandre, Girard, Marc, Ozakbas, Serkan, Grammond, Pierrre, Zephir, Helene, Ciron, Jonathan, Maillart, Elisabeth, Moreau, Thibault, Leray, Emmanuelle, Amato, MP, Labauge, P, Alroughani, R, Buzzard, K, Skibina, O, Terzi, M, Laplaud, DA, Berger, E, Grand'Maison, F, Lebrun-Frenay, C, Casey, Romain, Cartechini, E, Boz, C, Lechner-Scott, Jeanette, Clavelou, P, Stankoff, B, Prevost, J, Kappos, L, Pelletier, J, Shaygannejad, V, Yamout, B, Horakova, Dana, Khoury, SJ, Gerlach, O, Spitaleri, DLA, Van Pesch, V, Gout, O, Turkoglu, R, Heinzlef, O, Thouvenot, E, McCombe, PA, Soysal, A, Havrdova, Eva Kubala, Bourre, B, Slee, M, Castillo-Trivino, T, Bakchine, S, Ampapa, R, Butler, EG, Wahab, A, Macdonell, RA, Aguera-Morales, E, Cabre, P, Debouverie, Marc, Ben, NH, Van der Walt, A, Laureys, G, Van Hijfte, L, Ramo-Tello, CM, Maubeuge, N, Hodgkinson, S, Sanchez-Menoyo, JL, Barnett, MH, Labeyrie, C, Patti, Francesco, Vucic, S, Sidhom, Y, Gouider, R, Csepany, T, Sotoca, J, de Gans, K, Al-Asmi, A, Fragoso, YD, Vukusic, S, Butzkueven, H, De Seze, Jerome, Kalincik, T, Izquierdo, Guillermo. Wolters Kluwer Health; 2022. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.
Zhu, Chao, Kalincik, Tomas, Patti, Francesco, Grand'Maison, Francois, Hodgkinson, Suzanne, Grammond, Pierre, Lechner-Scott, Jeannette, Butler, Ernest, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Macdonell, Richard A. L., Horakova, Dana, Weinstock-Guttman, B, Ozakbas, S, Slee, M, Sa, MJ, Van Pesch, V, Barnett, M, Van Wijmeersch, B, Gerlach, O, Prevost, J, Terzi, M, Zhou, Zhen, Boz, C, Laureys, G, Van Hijfte, L, Kermode, AG, Garber, J, Yamout, B, Khoury, SJ, Merlo, D, Monif, M, Jokubaitis, V, Buzzard, Katherine, van der Walt, A, Butzkueven, H, MSBase, SG, Skibina, Olga, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Kuhle, Jens. American Medical Association (AMA); 2023. Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation.
Zhu, Chao, Zhou, Zhen, Alroughani, Raed, Lechner-Scott, Jeannette, Barnett, Michael, Izquierdo, Guillermo, Prat, Alexandre, Horakova, Dana, Havrdova, Eva Kubala, Macdonell, Richard, Patti, Francesco, Khoury, Samia Joseph, Roos, Izanne, Slee, M, Karabudak, R, Onofrj, M, Van Pesch, V, Prevost, J, Monif, M, Jokubaitis, V, van der Walt, A, Butzkueven, H, Merlo, Daniel, Kalincik, Tomas, Ozakbas, Serkan, Skibina, Olga, Kuhle, Jens, Hodgkinson, Suzanne, Boz, Cavit. BMJ Group; 2022. Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis.